Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Colorectal Neoplasms

  Free Subscription

Articles published in J Pathol

Retrieve available abstracts of 13 articles:
HTML format
Text format

Single Articles

    March 2018
  1. DEEVI RK, Javadi A, McClements J, Vohhodina J, et al
    Protein kinase C zeta suppresses low- or high-grade colorectal cancer (CRC) phenotypes by interphase centrosome anchoring.
    J Pathol. 2018 Mar 9. doi: 10.1002/path.5035.
    PubMed     Text format     Abstract available

    February 2018
  2. ALDERDICE M, Richman SD, Gollins S, Stewart P, et al
    Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.
    J Pathol. 2018 Feb 7. doi: 10.1002/path.5051.
    PubMed     Text format     Abstract available

    October 2017
  3. BINDER H, Hopp L, Schweiger MR, Hoffmann S, et al
    Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome.
    J Pathol. 2017;243:242-254.
    PubMed     Text format     Abstract available

    September 2017
  4. SHU XS, Zhao Y, Sun Y, Zhong L, et al
    PBRM1 restricts the basal activity of innate immune system through repressing RIG-I-like receptor signaling and is a potential prognostic biomarker for colon cancer.
    J Pathol. 2017 Sep 20. doi: 10.1002/path.4986.
    PubMed     Text format     Abstract available

    August 2017
  5. BARROW TM, Klett H, Toth R, Bohm J, et al
    Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study.
    J Pathol. 2017 Aug 9. doi: 10.1002/path.4955.
    PubMed     Text format     Abstract available

    June 2017
  6. IRSHAD S, Bansal M, Guarnieri P, Davis H, et al
    Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer.
    J Pathol. 2017;242:178-192.
    PubMed     Text format     Abstract available

    May 2017
  7. PILATI C, Shinde J, Alexandrov LB, Assie G, et al
    Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas.
    J Pathol. 2017;242:10-15.
    PubMed     Text format     Abstract available

  8. DE SMET F, Saiz Rubio M, Hompes D, Naus E, et al
    Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation.
    J Pathol. 2017;242:24-38.
    PubMed     Text format     Abstract available

    January 2017
  9. TORRES S, Garcia-Palmero I, Bartolome RA, Fernandez-Acenero MJ, et al
    Combined miRNA profiling and proteomics demonstrates that different miRNAs target a common set of proteins to promote colorectal cancer metastasis.
    J Pathol. 2017 Jan 5. doi: 10.1002/path.4874.
    PubMed     Text format     Abstract available

    December 2016
  10. LIN SC, Hsiao KY, Chang N, Hou PC, et al
    Loss of dual specificity phosphatase-2 promotes angiogenesis and metastasis via upregulation of interleukin-8 in colon cancer.
    J Pathol. 2016 Dec 27. doi: 10.1002/path.4868.
    PubMed     Text format     Abstract available

    October 2016
  11. SUN Y, Ji P, Chen T, Zhou X, et al
    MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.
    J Pathol. 2016 Oct 14. doi: 10.1002/path.4823.
    PubMed     Text format     Abstract available

    August 2016
  12. SHI W, Ye Z, Zhuang L, Li Y, et al
    Olfactomedin 1 negatively regulates NF-kB signalling and suppresses the growth and metastasis of colorectal cancer cells.
    J Pathol. 2016 Aug 24. doi: 10.1002/path.4784.
    PubMed     Text format     Abstract available

    January 2016
  13. RASHID M, Fischer A, Wilson CH, Tiffen J, et al
    Adenoma development in familial adenomatous polyposis and MUTYH-associated polyposis: somatic landscape and driver genes.
    J Pathol. 2016;238:98-108.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.